STOCK TITAN

Durect Corp (DRRX) Files Form 144 for 5,500-Share Sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Durect Corp (DRRX) filed a Form 144 reporting a proposed sale of 5,500 common shares through Morgan Stanley Smith Barney LLC on 09/10/2025. The filing shows the shares were acquired and will be paid for on 09/10/2025 via a stock option exercise and payment in cash. The aggregate market value of the shares at filing is reported as $10,623.80 and the issuer’s number of shares outstanding is listed as 31,054,187. The filer reports no securities sold in the past three months and includes the standard representation that they are not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small insider sale following option exercise; reported quantity is immaterial relative to outstanding shares and likely limited market impact.

The Form 144 documents a proposed sale of 5,500 shares acquired by stock option exercise and to be sold through Morgan Stanley Smith Barney LLC on 09/10/2025 for an aggregate reported market value of $10,623.80. Relative to the reported 31,054,187 shares outstanding, the proposed sale represents a very small fraction of the float. The filing does not report any sales in the prior three months and contains the standard attestation regarding material nonpublic information. Based solely on the information provided, this disclosure is a routine insider liquidity event without additional context indicating material company-level implications.

TL;DR: Routine compliance filing for a securities sale under Rule 144; no governance issues or disclosure red flags are evident in the notice.

The Form 144 shows compliance with Rule 144 requirements: identification of the broker, number of shares to be sold, acquisition method (stock option exercise), and representation regarding material information. There are no reported aggregated sales in the past three months. The filing does not disclose any additional governance matters, change in control, or restriction exceptions. Based strictly on the filing text, it appears to be a standard reporting of an insider sale opportunity rather than an indicator of governance concern.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed by Durect Corp (DRRX) report?

The Form 144 reports a proposed sale of 5,500 common shares to be sold through Morgan Stanley Smith Barney LLC on 09/10/2025, with an aggregate market value of $10,623.80.

How were the shares acquired according to the filing?

The filing states the shares were acquired on 09/10/2025 via a stock option exercise, and payment was made in cash on that date.

How many shares outstanding does the filing list for the issuer?

The Form 144 lists 31,054,187 shares outstanding for the issuer.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker named in the notice?

The broker named is Morgan Stanley Smith Barney LLC located at Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004.
DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.31M
27.26M
12.67%
23.58%
1.11%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO